Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centers for Disease Control and Prevention | FED |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to pilot and implement a peer mentor intervention focused on overdose prevention and care.
The intervention consists of 3 sessions. During the first and second session, each participant will meet individually with a trained staff member. In the 3rd session, the participant will invite a social network member to attend the session, and these 2 participants will meet with a trained staff member.
The specific aims of the study are:
There are two types of participants: Index participants and network participants. Both type of participant will currently used opiates. Participants will take part in a baseline visit and up to 3 follow-up visits. Index participants will be randomized into the intervention or control arm of the study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Peer Education | Experimental |
|
|
| Standard of care | Active Comparator |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Peer Education | Behavioral | In this intervention, people who use opiates will be trained to be peer educators. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Network Enrollment | The question will be: How many people in their social network did Index participants recruit to the study? Participants provide a number of 0 or higher. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Drug treatment entry | The question will be: In the past 12 months, did you enroll in a drug treatment program including a medically assisted treatment program? The response options are yes and no. | 12 months |
| Overdose Risk |
Not provided
Inclusion Criteria for Index participants:
Inclusion Criteria for network participants:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carl A. Latkin, PhD | Johns Hopkins Bloomberg School of Public Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lighthouse Studies at Peer Point | Baltimore | Maryland | 21205 | United States |
Not provided
| ID | Term |
|---|---|
| D062787 | Drug Overdose |
| ID | Term |
|---|---|
| D063487 | Prescription Drug Misuse |
| D000076064 | Drug Misuse |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
Not provided
Not provided
Index participants will be randomized into 1 of two study arms.
Not provided
Not provided
Not provided
Not provided
| Narcan Nasal Product | Drug | All study participants will be trained in how to use nasal Narcan and they will receive a nasal Narcan kit. |
|
Change in risk will be measured by a score that includes frequency of naloxone availability when using opiates, testing drugs before injecting, and drug use alone. Higher scores will indicate increased overdose risk. Scores will be measured from 0-9
| 12 months |
| D001523 | Mental Disorders |